ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

テトラゼパム

Tetrazepam

HCID 25215
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
10379-14-3
標準SMILES
CN1C(=O)CN=C(C2=CCCCC2)c2cc(Cl)ccc21
InChIKey
IQWYAQCHYZHJOS-UHFFFAOYSA-N
分子式
C16H17ClN2O
平均分子量
288.77 g/mol
単同位体質量
288.1029409

概要

Tetrazepam is a benzodiazepine.

名称と識別子

優先名称
Tetrazepam
IUPAC
7-chloro-5-(cyclohexen-1-yl)-1-methyl-3H-1,4-benzodiazepin-2-one
現地名
テトラゼパム
英語名
TETRAZEPAM
分子式
C16H17ClN2O
分子量
288.77

名称と別名

TetrazepamMyolastanMusarilClinoxan10379-14-3CB 4261CB-4261FO92091VP8DTXSID001460587-chloro-5-(cyclohex-1-en-1-yl)-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2h-1,4-benzodiazepin-2-oneRefChem:188914
名称をさらに表示
クリノキサンムサリルミオラスタン7-クロロ-5-(1-シクロヘキセン-1-イル)-1,3-ジヒドロ-1-メチル-2H-1,4-ベンゾジアゼピン-2-オンテトラゼパム7-クロロ-5-(シクロヘキサ-1-エン-1-イル)-1-メチル-2,3-ジヒドロ-1H-1,4-ベンゾジアゼピン-2-オンepineCS-3124261cb4361cbcb42614361 CB
DTXCID8068549233-837-7Ro 06-66574261 CB7-Chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one2H-1,4-BENZODIAZEPIN-2-ONE, 7-CHLORO-5-(1-CYCLOHEXEN-1-YL)-1,3-DIHYDRO-1-METHYL-Tetrazepam (INN)7-Chloro-5-(1-cyclohexenyl)-1-methyl-2-oxo-2,3-dihydro-1H-(1,4)-benzo(f)diazepine

データベース識別子

CAS
10379-14-3
PubChem CID
25215
DTXSID
DTXSID00146058
ChEMBL
CHEMBL2105527
ChEBI
CHEBI:135198
UNII
FO92091VP8
EC Number
233-837-7
Nikkaji
J10.468J

物性

構造計算による物性

XLogP
3.2
極性表面積
32.7 Ų
水素結合供与体数
0
水素結合受容体数
2
回転可能結合数
1
重原子数
20
形式電荷
0
複雑度
457

実験および物理化学的性質

Drugs · 5 件

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals

Pharmaceuticals -> Benzodiazepines

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP · 2 件

3.20

2.76

Melting Point144 °C
Physical DescriptionSolid

物理化学的性質

融点
144 ° · 144°
沸点
502.1 · 502.1±50.0 °C(Predicted)
比重(密度)
1.1741 · 1.1741 (rough estimate)
屈折率
1.58 · 1.5800 (estimate)
溶解性
水にほとんど溶けず、塩化メチレンに溶けやすく、アセトニトリルに溶ける。
酸解離定数(Pka)
4.1 · 4.10±0.10(Predicted)
CAS データベース
10379 · 10379-14-3

化学的性質

化学的特性Light yellow or yellow crystalline powder.

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H301 (40%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P261, P262, P264, P270, P271, P272, P273, P280, P301+P316, P301+P317, P302+P352, P304+P340, P316, P318, P319, P321, P330, P333+P317, P361+P364, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 5 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 2 件

DEA schedule IV controlled substance

2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 3 (40%)

毒性情報

Treatment · 1 件

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Toxicity Summary · 1 件

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 4 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Tetrazepam

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

安全データ

毒性
LD50 in mice (mg/kg): 415 i.p.; 2000 orally (Schmitt)
DEA Controlled Substances
CSCN: 2886CSA SCH: Schedule IVNARC: No

化学と産業

薬理情報

ATC Code · 2 件

M - Musculo-skeletal system

QM - Musculo-skeletal system

MeSH Pharmacological Classification · 1 件

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)

Cellular LocationsMembrane

用途と製造

Uses · 2 件

Use (kg; approx.) in Germany (2009): >2500

Tetrazepam is used to treat muscle spasm, anxiety disorders such as panic attacks, or more rarely to treat depression, premenstrual syndrome or agoraphobia.

応用分野

使用Tetrazepam is a muscle relaxant (skeletal). This is a controlled substance (depressant).

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート